ZENOTECHPharmaceuticals
Zenotech Laboratories Ltd — Balance Sheet
₹34.29
-5.60%
Zenotech Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 6.10 Cr | 6.10 Cr | 6.10 Cr | 6.10 Cr | — |
| Share Issued | 6.10 Cr | 6.10 Cr | 6.10 Cr | 6.10 Cr | — |
| Total Debt | 0.00 | 0.00 | 0.00 | 6.00 Cr | — |
| Tangible Book Value | 96.13 Cr | 90.54 Cr | 82.27 Cr | 70.64 Cr | — |
| Invested Capital | 96.13 Cr | 90.54 Cr | 82.27 Cr | 76.64 Cr | — |
| Working Capital | 23.40 Cr | 12.64 Cr | -0.34 Cr | -8.20 Cr | — |
| Net Tangible Assets | 96.13 Cr | 90.54 Cr | 82.27 Cr | 70.64 Cr | — |
| Common Stock Equity | 96.13 Cr | 90.54 Cr | 82.27 Cr | 70.64 Cr | — |
| Total Capitalization | 96.13 Cr | 90.54 Cr | 82.27 Cr | 76.64 Cr | — |
| Total Equity Gross Minority Interest | 96.13 Cr | 90.54 Cr | 82.27 Cr | 70.64 Cr | — |
| Stockholders Equity | 96.13 Cr | 90.54 Cr | 82.27 Cr | 70.64 Cr | — |
| Other Equity Interest | 35.10 Cr | — | 21.24 Cr | 9.61 Cr | — |
| Capital Stock | 61.03 Cr | 61.03 Cr | 61.03 Cr | 61.03 Cr | — |
| Common Stock | 61.03 Cr | 61.03 Cr | 61.03 Cr | 61.03 Cr | — |
| Total Liabilities Net Minority Interest | 14.90 Cr | 15.66 Cr | 18.60 Cr | 23.44 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.31 Cr | 2.14 Cr | 2.00 Cr | 7.87 Cr | — |
| Other Non Current Liabilities | 0.09 Cr | 0.97 Cr | 0.97 Cr | 0.98 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 6.00 Cr | — |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 6.00 Cr | — |
| Long Term Provisions | 1.34 Cr | 1.17 Cr | 1.02 Cr | 0.89 Cr | — |
| Current Liabilities | 12.59 Cr | 13.52 Cr | 16.61 Cr | 15.58 Cr | — |
| Other Current Liabilities | 1.56 Cr | 1.06 Cr | 1.12 Cr | 1.18 Cr | — |
| Current Provisions | 4.45 Cr | 6.37 Cr | 8.27 Cr | 8.29 Cr | — |
| Payables | 3.74 Cr | 6.10 Cr | 7.22 Cr | 6.11 Cr | — |
| Total Tax Payable | 1.22 Cr | — | — | — | — |
| Accounts Payable | 2.52 Cr | 2.81 Cr | 3.48 Cr | 2.07 Cr | — |
| Total Assets | 111.03 Cr | 106.21 Cr | 100.87 Cr | 94.08 Cr | — |
| Total Non Current Assets | 75.04 Cr | 80.04 Cr | 84.61 Cr | 86.71 Cr | — |
| Other Non Current Assets | 0.09 Cr | -51000.00 | 1000.00 | 1000.00 | — |
| Non Current Deferred Taxes Assets | 3.94 Cr | 6.53 Cr | 9.36 Cr | 12.27 Cr | — |
| Investmentin Financial Assets | 1.45 Cr | 0.03 Cr | 0.00 | 0.00 | — |
| Available For Sale Securities | 1.45 Cr | 0.03 Cr | 1.35 Cr | 0.78 Cr | — |
| Net PPE | 64.44 Cr | 67.54 Cr | 70.36 Cr | 71.19 Cr | — |
| Gross PPE | 64.44 Cr | 116.00 Cr | 111.76 Cr | 105.41 Cr | — |
| Construction In Progress | 3.57 Cr | 1.96 Cr | 4.98 Cr | 0.28 Cr | — |
| Other Properties | 60.87 Cr | 2.09 Cr | 1.99 Cr | 1.82 Cr | — |
| Current Assets | 35.99 Cr | 26.16 Cr | 16.26 Cr | 7.37 Cr | — |
| Other Current Assets | 0.64 Cr | 0.79 Cr | 1.12 Cr | 0.81 Cr | — |
| Inventory | 0.00 | 0.84 Cr | 0.00 | 0.06 Cr | — |
| Accounts Receivable | 7.45 Cr | 3.25 Cr | 3.32 Cr | 3.93 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 27.90 Cr | 19.70 Cr | 11.14 Cr | 2.41 Cr | — |
| Other Short Term Investments | 1.32 Cr | 17.89 Cr | 0.68 Cr | 0.16 Cr | — |
| Cash And Cash Equivalents | 26.58 Cr | 1.82 Cr | 11.14 Cr | 2.41 Cr | — |
| Retained Earnings | — | -180.03 Cr | -188.30 Cr | -199.93 Cr | -222.17 Cr |
| Additional Paid In Capital | — | 209.54 Cr | 209.54 Cr | 209.54 Cr | 209.54 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 1.17 Cr | 1.02 Cr | 0.89 Cr | 0.83 Cr |
| Other Payable | — | 3.29 Cr | 3.74 Cr | 4.04 Cr | 3.48 Cr |
| Non Current Prepaid Assets | — | 1.39 Cr | 1.40 Cr | 0.95 Cr | 0.79 Cr |
| Long Term Equity Investment | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Investmentsin Subsidiariesat Cost | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Accumulated Depreciation | — | -48.47 Cr | -41.39 Cr | -34.22 Cr | -27.25 Cr |
| Machinery Furniture Equipment | — | 89.68 Cr | 82.51 Cr | 81.03 Cr | 77.62 Cr |
| Buildings And Improvements | — | 21.20 Cr | 21.20 Cr | 21.20 Cr | 21.01 Cr |
| Land And Improvements | — | 1.08 Cr | 1.08 Cr | 1.08 Cr | 1.08 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 0.84 Cr | 1.12 Cr | 0.81 Cr | 0.87 Cr |
| Work In Process | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Raw Materials | — | 0.84 Cr | 0.00 | 0.06 Cr | 0.06 Cr |
| Other Receivables | — | 1.53 Cr | 0.68 Cr | 0.16 Cr | 0.15 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Accounts Receivable | — | 3.25 Cr | 3.32 Cr | 3.93 Cr | 3.80 Cr |
| Cash Equivalents | — | 0.00 | 10.00 Cr | 0.00 | 0.00 |
| Cash Financial | — | 1.82 Cr | 1.14 Cr | 2.41 Cr | 2.46 Cr |
| Net Debt | — | — | — | 3.59 Cr | 18.20 Cr |
| Current Debt And Capital Lease Obligation | — | — | — | 0.00 | 0.00 |
| Current Debt | — | — | — | 0.00 | 0.00 |
| Taxes Receivable | — | — | — | 0.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Zenotech Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.